If you're taking a GLP-1 drug like Ozempic or Wegovy, you might be wondering whether you'll need to stay on it indefinitely. Experts are increasingly discussing the long-term safety and necessity of these medications, since weight often returns when people stop taking them.
Posts published in “GLP-1”
Many telehealth companies are making GLP-1 weight loss drugs easily available online as demand soars. This easy access is raising concerns about potential overdoses and safety issues when these powerful medications aren't properly supervised by healthcare providers.
Medicare beneficiaries will be able to get coverage for GLP-1 medications for weight loss starting in 2026. Currently, Medicare covers these drugs for specific conditions like type 2 diabetes, but the expanded coverage will include weight management.
New research suggests GLP-1 weight loss drugs might be changing how the brain and nervous system function. Scientists are investigating whether these medications could have broader effects on brain structure and neural networks beyond their intended weight loss benefits.
The latest Oura Ring includes blood pressure monitoring and tools to track GLP-1 medications alongside existing health features. The smart ring is expanding beyond sleep and fitness to offer comprehensive health monitoring including medical record integration.
Oura Ring is introducing new features that let users track their GLP-1 doses, log symptoms, and monitor long-term health trends. The wearable device is expanding beyond fitness tracking to help people manage their weight loss medication journey.
CVS Caremark is expanding coverage options for GLP-1 weight management medications to make them more affordable and accessible. The expanded coverage aims to create sustainable access to these important medications for more members.
Healthcare providers are alarmed to find patients with anorexia, bulimia, and binge eating disorders are taking GLP-1 weight loss drugs. This trend is raising serious concerns about the safety of these medications for people with existing eating disorders.